Johnson & Johnson Acquisitions, Net of Cash Acquired
Johnson & Johnson (JNJ) reported Acquisitions, Net of Cash Acquired of $263.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-07-23
- Johnson & Johnson payments to acquire businesses, net of cash acquired for the quarter ending 2026-06-28 was -$17.24B, a 219.22% decline year-over-year.
- Johnson & Johnson payments to acquire businesses, net of cash acquired for the quarter ending 2026-03-29 was $17.50B.
- Johnson & Johnson payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-28 was $3.04B, a 304000.00% increase year-over-year.
- Johnson & Johnson payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-28 was $1.00M, a 99.70% decline year-over-year.
- Johnson & Johnson payments to acquire businesses, net of cash acquired for fiscal 2024 was $15.15B.
- Johnson & Johnson payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2023.
- Johnson & Johnson payments to acquire businesses, net of cash acquired for fiscal 2023 was $17.65B, a 29320.00% increase from fiscal 2022.
- Johnson & Johnson payments to acquire businesses, net of cash acquired for fiscal 2022 was $60.00M, a 99.18% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-28 | -$17.24B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $263.00M 10-Q · filed 2026-07-23 | $3.30B derived: sum of 3 quarters · filed 2026-07-23 | $3.31B derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2026-03-29 | $17.50B 10-Q · filed 2026-07-23 | $20.54B derived: sum of 2 quarters · filed 2026-07-23 | $20.54B derived: sum of 3 quarters · filed 2026-07-23 | $35.00B derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-12-28 | $3.04B derived: 10-Q 12 month − 10-Q 9 month · filed 2026-04-22 | $3.04B derived: sum of 2 quarters · filed 2026-04-22 | $17.50B derived: sum of 3 quarters · filed 2026-07-23 | $17.50B 10-Q · filed 2026-04-22 | $17.54B 10-K · filed 2026-02-11 | |
| 2025-09-28 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $14.46B derived: sum of 2 quarters · filed 2026-07-23 | $14.46B 10-Q · filed 2025-10-22 | $14.46B derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-06-29 | $14.46B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $14.46B 10-Q · filed 2026-07-23 | $14.46B derived: sum of 3 quarters · filed 2026-07-23 | $14.80B derived: sum of 4 quarters · filed 2026-07-23 | ||
| 2025-03-30 | $0.00 10-Q · filed 2025-04-23 | $1.00M derived: sum of 2 quarters · filed 2026-02-11 | $339.00M derived: sum of 3 quarters · filed 2026-02-11 | $13.34B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-12-29 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $339.00M derived: sum of 2 quarters · filed 2026-02-11 | $13.34B derived: sum of 3 quarters · filed 2026-02-11 | $15.15B 10-K · filed 2026-02-11 | ||
| 2024-09-29 | $338.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $13.33B derived: sum of 2 quarters · filed 2025-10-22 | $15.14B 10-Q · filed 2025-10-22 | $15.14B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-06-30 | $13.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $14.81B 10-Q · filed 2025-07-24 | $14.81B derived: sum of 3 quarters · filed 2026-02-11 | $14.81B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-03-31 | $1.81B 10-Q · filed 2025-04-23 | $1.81B derived: sum of 2 quarters · filed 2026-02-11 | $1.81B derived: sum of 3 quarters · filed 2026-02-11 | $1.81B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-02-11 | $0.00 10-K · filed 2026-02-11 | ||
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-23 | $0.00 derived: sum of 2 quarters · filed 2024-10-23 | $0.00 10-Q · filed 2024-10-23 | $17.13B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $0.00 10-Q · filed 2024-07-25 | $17.13B derived: sum of 3 quarters · filed 2025-02-13 | $17.13B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-04-02 | $0.00 10-Q · filed 2024-05-01 | $17.13B derived: sum of 2 quarters · filed 2025-02-13 | $17.13B derived: sum of 3 quarters · filed 2025-02-13 | $17.40B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-01-01 | $17.13B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $17.13B derived: sum of 2 quarters · filed 2025-02-13 | $17.40B derived: sum of 3 quarters · filed 2025-02-13 | $17.65B 10-K · filed 2025-02-13 | ||
| 2022-10-02 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $270.00M derived: sum of 2 quarters · filed 2023-10-27 | $522.00M 10-Q · filed 2023-10-27 | $582.00M derived: sum of 4 quarters · filed 2024-02-16 | ||
| 2022-07-03 | $271.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $523.00M 10-Q · filed 2023-07-31 | $583.00M derived: sum of 3 quarters · filed 2024-02-16 | $583.00M derived: sum of 4 quarters · filed 2024-02-16 | ||
| 2022-04-03 | $252.00M 10-Q · filed 2023-04-28 | $312.00M derived: sum of 2 quarters · filed 2024-02-16 | $312.00M derived: sum of 3 quarters · filed 2024-02-16 | $312.00M derived: sum of 4 quarters · filed 2024-02-16 | ||
| 2022-01-02 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $60.00M derived: sum of 2 quarters · filed 2024-02-16 | $60.00M derived: sum of 3 quarters · filed 2024-02-16 | $60.00M 10-K · filed 2024-02-16 | ||
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $0.00 derived: sum of 2 quarters · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | $6.37B derived: sum of 4 quarters · filed 2023-02-16 | ||
| 2021-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $0.00 10-Q · filed 2022-07-29 | $6.37B derived: sum of 3 quarters · filed 2023-02-16 | $6.37B derived: sum of 4 quarters · filed 2023-02-16 | ||
| 2021-04-04 | $0.00 10-Q · filed 2022-04-29 | $6.37B derived: sum of 2 quarters · filed 2023-02-16 | $6.37B derived: sum of 3 quarters · filed 2023-02-16 | $6.38B derived: sum of 4 quarters · filed 2023-02-16 | ||
| 2021-01-03 | $6.37B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $6.37B derived: sum of 2 quarters · filed 2023-02-16 | $6.38B derived: sum of 3 quarters · filed 2023-02-16 | $7.32B 10-K · filed 2023-02-16 | ||
| 2020-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $10.00M derived: sum of 2 quarters · filed 2021-10-29 | $949.00M 10-Q · filed 2021-10-29 | $1.20B derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-06-28 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $949.00M 10-Q · filed 2021-07-29 | $1.20B derived: sum of 3 quarters · filed 2022-02-17 | $1.41B derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2020-03-29 | $939.00M 10-Q · filed 2021-04-30 | $1.19B derived: sum of 2 quarters · filed 2022-02-17 | $1.40B derived: sum of 3 quarters · filed 2022-02-17 | $5.07B derived: sum of 4 quarters · filed 2022-02-17 | ||
| 2019-12-29 | $248.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $464.00M derived: sum of 2 quarters · filed 2022-02-17 | $4.13B derived: sum of 3 quarters · filed 2022-02-17 | $5.81B 10-K · filed 2022-02-17 | ||
| 2019-09-29 | $216.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $3.88B derived: sum of 2 quarters · filed 2020-10-23 | $5.56B 10-Q · filed 2020-10-23 | $5.56B derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2019-06-30 | $3.66B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $5.35B 10-Q · filed 2020-07-24 | $5.35B derived: sum of 3 quarters · filed 2021-02-22 | $6.02B derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2019-03-31 | $1.68B 10-Q · filed 2020-04-29 | $1.69B derived: sum of 2 quarters · filed 2021-02-22 | $2.36B derived: sum of 3 quarters · filed 2021-02-22 | $2.50B derived: sum of 4 quarters · filed 2021-02-22 | ||
| 2018-12-30 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $677.00M derived: sum of 2 quarters · filed 2021-02-22 | $817.00M derived: sum of 3 quarters · filed 2021-02-22 | $899.00M 10-K · filed 2021-02-22 | ||
| 2018-09-30 | $675.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $815.00M derived: sum of 2 quarters · filed 2019-10-28 | $897.00M 10-Q · filed 2019-10-28 | $1.40B derived: sum of 4 quarters · filed 2020-02-18 | ||
| 2018-07-01 | $140.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $222.00M 10-Q · filed 2019-07-29 | $727.00M derived: sum of 3 quarters · filed 2020-02-18 | $1.30B derived: sum of 4 quarters · filed 2020-02-18 | ||
| 2018-04-01 | $82.00M 10-Q · filed 2019-05-01 | $587.00M derived: sum of 2 quarters · filed 2020-02-18 | $1.16B derived: sum of 3 quarters · filed 2020-02-18 | $30.38B derived: sum of 4 quarters · filed 2020-02-18 | ||
| 2017-12-31 | $505.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $1.08B derived: sum of 2 quarters · filed 2020-02-18 | $30.30B derived: sum of 3 quarters · filed 2020-02-18 | $35.15B 10-K · filed 2020-02-18 | ||
| 2017-10-01 | $574.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $29.79B derived: sum of 2 quarters · filed 2018-10-31 | $34.65B 10-Q · filed 2018-10-31 | $35.10B derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-07-02 | $29.22B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $34.07B 10-Q · filed 2018-08-02 | $34.53B derived: sum of 3 quarters · filed 2019-02-20 | $37.85B derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-04-02 | $4.85B 10-Q · filed 2018-05-01 | $5.31B derived: sum of 2 quarters · filed 2019-02-20 | $8.63B derived: sum of 3 quarters · filed 2019-02-20 | $9.36B derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-01-01 | $459.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $3.78B derived: sum of 2 quarters · filed 2019-02-20 | $4.50B derived: sum of 3 quarters · filed 2019-02-20 | $4.51B 10-K · filed 2019-02-20 | ||
| 2016-10-02 | $3.32B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $4.04B derived: sum of 2 quarters · filed 2017-11-02 | $4.05B 10-Q · filed 2017-11-02 | $4.77B derived: sum of 4 quarters · filed 2018-02-21 | ||
| 2016-07-03 | $725.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $730.00M 10-Q · filed 2017-08-03 | $1.45B derived: sum of 3 quarters · filed 2018-02-21 | $1.45B derived: sum of 4 quarters · filed 2018-02-21 | ||
| 2016-04-03 | $5.00M 10-Q · filed 2017-05-08 | $726.00M derived: sum of 2 quarters · filed 2018-02-21 | $726.00M derived: sum of 3 quarters · filed 2018-02-21 | $726.00M derived: sum of 4 quarters · filed 2018-02-21 | ||
| 2016-01-03 | $721.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $721.00M derived: sum of 2 quarters · filed 2018-02-21 | $721.00M derived: sum of 3 quarters · filed 2018-02-21 | $954.00M 10-K · filed 2018-02-21 | ||
| 2015-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $233.00M 10-Q · filed 2016-11-04 | $2.07B derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $233.00M 10-Q · filed 2016-08-04 | $2.07B derived: sum of 3 quarters · filed 2017-02-27 | $2.36B derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-03-29 | $233.00M 10-Q · filed 2016-05-10 | $2.07B derived: sum of 2 quarters · filed 2017-02-27 | $2.36B derived: sum of 3 quarters · filed 2017-02-27 | $2.36B derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2014-12-28 | $1.84B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.13B derived: sum of 2 quarters · filed 2017-02-27 | $2.13B derived: sum of 3 quarters · filed 2017-02-27 | $2.13B 10-K · filed 2017-02-27 | ||
| 2014-09-28 | $291.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $291.00M derived: sum of 2 quarters · filed 2015-10-30 | $291.00M 10-Q · filed 2015-10-30 | $307.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $0.00 10-Q · filed 2015-07-31 | $16.00M derived: sum of 3 quarters · filed 2016-02-24 | $661.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-30 | $0.00 10-Q · filed 2015-05-01 | $16.00M derived: sum of 2 quarters · filed 2016-02-24 | $661.00M derived: sum of 3 quarters · filed 2016-02-24 | $667.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-29 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $661.00M derived: sum of 2 quarters · filed 2016-02-24 | $667.00M derived: sum of 3 quarters · filed 2016-02-24 | $835.00M 10-K · filed 2016-02-24 | ||
| 2013-09-29 | $645.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $651.00M derived: sum of 2 quarters · filed 2014-10-30 | $819.00M 10-Q · filed 2014-10-30 | $882.00M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $174.00M 10-Q · filed 2014-08-01 | $237.00M derived: sum of 3 quarters · filed 2015-02-24 | $336.00M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $168.00M 10-Q · filed 2014-05-02 | $231.00M derived: sum of 2 quarters · filed 2015-02-24 | $330.00M derived: sum of 3 quarters · filed 2015-02-24 | $4.65B derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-30 | $63.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $162.00M derived: sum of 2 quarters · filed 2015-02-24 | $4.49B derived: sum of 3 quarters · filed 2015-02-24 | $4.49B 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $99.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $4.42B derived: sum of 2 quarters · filed 2013-11-04 | $4.42B 10-Q · filed 2013-11-04 | $4.75B derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-07-01 | $4.32B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $4.32B 10-Q · filed 2013-08-01 | $17.66B 10-Q · filed 2012-08-02 | $4.65B derived: sum of 3 quarters · filed 2014-02-21 | $5.07B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-04-01 | $0.00 10-Q · filed 2013-05-03 | $328.00M derived: sum of 2 quarters · filed 2014-02-21 | $748.00M derived: sum of 3 quarters · filed 2014-02-21 | $748.00M derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-01-01 | $328.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $748.00M derived: sum of 2 quarters · filed 2014-02-21 | $748.00M derived: sum of 3 quarters · filed 2014-02-21 | $2.80B 10-K · filed 2014-02-21 | ||
| 2011-10-02 | $420.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $420.00M derived: sum of 2 quarters · filed 2012-11-09 | $2.47B 10-Q · filed 2012-11-09 | $2.47B derived: sum of 4 quarters · filed 2013-02-22 | ||
| 2011-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $2.05B 10-Q · filed 2012-08-02 | $2.05B derived: sum of 3 quarters · filed 2013-02-22 | $2.45B derived: sum of 4 quarters · filed 2013-02-22 | ||
| 2011-04-03 | $2.05B 10-Q · filed 2012-05-07 | $2.05B derived: sum of 2 quarters · filed 2013-02-22 | $2.45B derived: sum of 3 quarters · filed 2013-02-22 | $2.55B derived: sum of 4 quarters · filed 2013-02-22 | ||
| 2011-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $398.00M derived: sum of 2 quarters · filed 2013-02-22 | $497.00M derived: sum of 3 quarters · filed 2013-02-22 | $1.27B 10-K · filed 2013-02-22 | ||
| 2010-10-03 | $398.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $497.00M derived: sum of 2 quarters · filed 2011-11-08 | $1.27B 10-Q · filed 2011-11-08 | $1.40B derived: sum of 4 quarters · filed 2012-02-23 | ||
| 2010-07-04 | $99.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $871.00M 10-Q · filed 2011-08-09 | $1.00B derived: sum of 3 quarters · filed 2012-02-23 | $2.05B derived: sum of 4 quarters · filed 2012-02-23 | ||
| 2010-04-04 | $772.00M 10-Q · filed 2011-05-10 | $905.00M derived: sum of 2 quarters · filed 2012-02-23 | $1.95B derived: sum of 3 quarters · filed 2012-02-23 | $1.95B derived: sum of 4 quarters · filed 2012-02-23 | ||
| 2010-01-03 | $133.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $1.18B derived: sum of 2 quarters · filed 2012-02-23 | $1.18B derived: sum of 3 quarters · filed 2012-02-23 | $2.47B 10-K · filed 2012-02-23 | ||
| 2009-09-27 | $1.05B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | $1.05B derived: sum of 2 quarters · filed 2010-11-10 | $2.34B 10-Q · filed 2010-11-10 | $3.15B derived: sum of 4 quarters · filed 2011-02-25 | ||
| 2009-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-11 | $1.29B 10-Q · filed 2010-08-11 | $2.10B derived: sum of 3 quarters · filed 2011-02-25 | $2.46B derived: sum of 4 quarters · filed 2011-02-25 | ||
| 2009-03-29 | $1.29B 10-Q · filed 2010-05-10 | $2.10B derived: sum of 2 quarters · filed 2011-02-25 | $2.46B derived: sum of 3 quarters · filed 2011-02-25 | |||
| 2008-12-28 | $814.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $1.17B derived: sum of 2 quarters · filed 2011-02-25 | $1.21B 10-K · filed 2011-02-25 | |||
| 2008-09-28 | $354.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-04 | $400.00M 10-Q · filed 2009-11-04 | ||||
| 2008-06-29 | $46.00M 10-Q · filed 2009-08-04 | |||||
| 2007-12-30 | $1.39B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |